ChemImpex Cefotiam dihydrochloride hydrate; 98% (Assay: Anhydrous basis); 66309-69-1; MFCD20488053, 5G

Cefotiam dihydrochloride hydrate is a broad-spectrum cephalosporin antibiotic known for its effectiveness against a variety of bacterial infections. This compound is particularly valuable in clinical settings, where it is utilized for treating respiratory tract infections, urinary tract infections, and skin infections caused by susceptible organisms. Its unique structure allows it to penetrate bacterial cell walls efficiently, making it a potent choice for combating resistant strains. Researchers and healthcare professionals appreciate Cefotiam for its favorable pharmacokinetic properties, which include good oral bioavailability and a relatively low incidence of adverse effects, enhancing patient compliance.

In addition to its therapeutic applications, Cefotiam dihydrochloride hydrate is also employed in pharmaceutical research and development, where it serves as a reference compound in the study of antibiotic resistance mechanisms. Its versatility and effectiveness make it an essential tool for both clinicians and researchers aiming to improve patient outcomes and advance the understanding of antibiotic efficacy. With ongoing studies exploring its potential in combination therapies, Cefotiam continues to hold promise in the fight against infectious diseases.

Specifications

Safety & Regulations